NGeneBio Co., Ltd. (KOSDAQ:354200)
South Korea · Delayed Price · Currency is KRW 1,687.00
-3.00 (-0.18%)
At close: Apr 24, 2026
NGeneBio Market Cap
NGeneBio has a market cap or net worth of 45.23 billion as of April 24, 2026. Its market cap has increased by 48.86% in one year.
Market Cap
45.23B
Enterprise Value
72.43B
Revenue
21.24B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,687.00
Market Cap Chart
Since December 10, 2020, NGeneBio's market cap has decreased from 313.33B to 45.23B, a decrease of -85.57%. That is a compound annual growth rate of -30.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2026 | 45.31B | 23.94% |
| Dec 30, 2025 | 36.56B | 12.79% |
| Dec 30, 2024 | 32.41B | -54.77% |
| Dec 28, 2023 | 71.66B | -38.23% |
| Dec 29, 2022 | 116.03B | -42.38% |
| Dec 30, 2021 | 201.38B | -46.99% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HLB Pep | 68.12B |
| Aptamer Sciences | 67.95B |
| EyeGene | 63.81B |
| ADBiotech | 54.91B |
| J2KBIO | 48.65B |
| Parataxis Korea | 44.13B |
| SCM Lifescience | 40.98B |
| MOA Life Plus | 38.67B |